| scholarly article | Q13442814 |
| P50 | author | Sergey Shchelkunov | Q4528657 |
| P2860 | cites work | A new inhibitor of apoptosis from vaccinia virus and eukaryotes | Q21131614 |
| The F-box protein family. | Q21194893 | ||
| Cullin-RING ubiquitin ligases: global regulation and activation cycles | Q21203558 | ||
| The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax | Q24310440 | ||
| Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein | Q24319056 | ||
| cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family | Q24336422 | ||
| Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7 | Q24338222 | ||
| Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei | Q24555699 | ||
| BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase | Q24558689 | ||
| cDNA sequence for human erythrocyte ankyrin | Q24558769 | ||
| The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase | Q24561643 | ||
| Systematic analysis and nomenclature of mammalian F-box proteins | Q24561715 | ||
| Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections | Q24563791 | ||
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| Innate immune sensing of DNA viruses | Q24626598 | ||
| Poxvirus pathogenesis | Q24634729 | ||
| The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms | Q24642586 | ||
| Origin and function of ubiquitin-like proteins | Q24651141 | ||
| Sequence and structural analysis of BTB domain proteins | Q24812693 | ||
| Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein | Q27649568 | ||
| Vaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than Apoptosis | Q27651621 | ||
| Inhibition of Apoptosis and NF-κB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence | Q27676390 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex | Q39953355 | ||
| Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. | Q40122897 | ||
| Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. | Q40214772 | ||
| Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. | Q40280943 | ||
| Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved | Q40305867 | ||
| Vaccinia virus-induced microtubule-dependent cellular rearrangements | Q40312383 | ||
| Functional organization of variola major and vaccinia virus genomes | Q40372624 | ||
| Natural human infections with Vaccinia virus during bovine vaccinia outbreaks. | Q40396299 | ||
| Effects of deletions of kelch-like genes on cowpox virus biological properties | Q40436338 | ||
| The poxvirus p28 virulence factor is an E3 ubiquitin ligase | Q40501664 | ||
| An evolutionary and functional approach to the TNF receptor/ligand family | Q40699318 | ||
| Tumor necrosis factor: a pleiotropic cytokine and therapeutic target | Q40759728 | ||
| Alastrim smallpox variola minor virus genome DNA sequences | Q40905542 | ||
| One step ahead of the game: viral immunomodulatory molecules | Q41039669 | ||
| Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. | Q41047354 | ||
| Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins | Q41349480 | ||
| Microorganisms and their interaction with the immune system. | Q41614591 | ||
| Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase | Q41659163 | ||
| DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister | Q41722728 | ||
| Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection | Q42023832 | ||
| Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication | Q42117156 | ||
| Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication | Q42122542 | ||
| Central modules of the vaccinia virus complement control protein are not in extensive contact | Q42158637 | ||
| Encoding of a homolog of the IFN-gamma receptor by myxoma virus | Q42605801 | ||
| Nucleotide sequence of XhoI O fragment of ectromelia virus DNA reveals significant differences from vaccinia virus | Q42610824 | ||
| The genomic sequence of ectromelia virus, the causative agent of mousepox | Q42615527 | ||
| Deletion of 55 open reading frames from the termini of vaccinia virus | Q42626327 | ||
| Terminal region sequence variations in variola virus DNA. | Q42631935 | ||
| Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara | Q42637410 | ||
| Species-specific differences in the structure of orthopoxvirus complement-binding protein | Q42662567 | ||
| Human monkeypox and smallpox viruses: genomic comparison. | Q42664957 | ||
| The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins | Q42676735 | ||
| Analysis of the monkeypox virus genome | Q42679073 | ||
| Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses | Q42679832 | ||
| Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola major virus strain India-1967. | Q42689843 | ||
| A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history | Q42717454 | ||
| Animal poxviruses transmitted from cat to man: current event with lethal end | Q43208749 | ||
| Cowpox infection causing a generalized eruption in a patient with atopic dermatitis | Q43213037 | ||
| A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. | Q43587591 | ||
| Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms | Q43604360 | ||
| Species-specific differences in organization of orthopoxvirus kelch-like proteins | Q43838742 | ||
| Investigation of the impact of cowpox virus BTB/kelch gene deletion on some characteristics of infection in vitro | Q43915406 | ||
| F-box-like domains are present in most poxvirus ankyrin repeat proteins | Q43986616 | ||
| Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus | Q45034493 | ||
| The time scale in poxvirus evolution | Q45207603 | ||
| Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules | Q45408166 | ||
| The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model | Q45722229 | ||
| The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein | Q45763563 | ||
| Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha | Q45768255 | ||
| Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity | Q45785576 | ||
| Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase | Q45795607 | ||
| Does the cytoskeleton play a significant role in animal virus replication? | Q45798533 | ||
| Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon | Q45859752 | ||
| A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection | Q45872018 | ||
| Transcription of both DNA strands of vaccinia virus genome in vivo | Q45890507 | ||
| Novel complement inhibitors | Q47771165 | ||
| Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat | Q47841519 | ||
| Comparative studies of gamma-interferon receptor-like proteins of variola major and variola minor viruses | Q48065597 | ||
| Two types of deletions in orthopoxvirus genomes | Q48075345 | ||
| Ankyrin-like proteins of variola and vaccinia viruses | Q48129119 | ||
| A truncated two-alpha-helix F-box present in poxvirus ankyrin-repeat proteins is sufficient for binding the SCF1 ubiquitin ligase complex. | Q51783355 | ||
| A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. | Q52515649 | ||
| [Orthopoxvirus genes for kelch-like proteins. III. Construction of mousepox (ectromelia) virus variants with targeted gene deletions] | Q53875406 | ||
| Comparative assessment of the properties of orthopoxviral soluble receptors for tumor necrosis factor. | Q54518968 | ||
| Molecular mimicry and the generation of host defense protein diversity | Q70623063 | ||
| [Immunomodulatory proteins of orthopoxviruses] | Q73096867 | ||
| Interleukin-18: a novel cytokine that augments both innate and acquired immunity | Q77355821 | ||
| Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting | Q79828292 | ||
| Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. | Q39753158 | ||
| Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins | Q39758342 | ||
| The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. | Q39761790 | ||
| RING finger proteins: mediators of ubiquitin ligase activity | Q28139717 | ||
| Buffalopox: an emerging and re-emerging zoonosis | Q28240313 | ||
| Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins | Q28297889 | ||
| Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence | Q28300302 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Chemokines | Q29616435 | ||
| One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil? | Q33348061 | ||
| Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses | Q33447166 | ||
| The inflammasomes. | Q33521252 | ||
| IL-1beta processing in host defense: beyond the inflammasomes | Q33535878 | ||
| Vaccinia virus protein F1L is a caspase-9 inhibitor | Q33648434 | ||
| SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family | Q33729691 | ||
| Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain | Q33781751 | ||
| Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses | Q33782567 | ||
| Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel [...] | Q33805943 | ||
| CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. | Q33834737 | ||
| Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model | Q33835582 | ||
| Viral mechanisms of immune evasion | Q34011092 | ||
| Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement | Q34066011 | ||
| Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine. | Q34107071 | ||
| Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo | Q34136736 | ||
| Complement and viral pathogenesis | Q34162421 | ||
| Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins | Q34168584 | ||
| Poxviruses and immune evasion | Q34172411 | ||
| Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. | Q34328870 | ||
| Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles | Q34434835 | ||
| Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors | Q34441628 | ||
| Cowpox with severe generalized eruption, Finland | Q34560041 | ||
| A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus | Q34596242 | ||
| How long ago did smallpox virus emerge? | Q34613410 | ||
| Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching | Q34810232 | ||
| Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. | Q35740993 | ||
| Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages | Q35840927 | ||
| Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity | Q35843985 | ||
| A third distinct tumor necrosis factor receptor of orthopoxviruses | Q36010238 | ||
| Poxvirus-induced alteration of arachidonate metabolism | Q36147156 | ||
| Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D | Q36229447 | ||
| Ectromelia virus: the causative agent of mousepox | Q36269022 | ||
| The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense | Q36370571 | ||
| Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence | Q36403362 | ||
| An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. | Q36424497 | ||
| The ubiquitin-proteasome pathway in viral infections | Q36538328 | ||
| Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans. | Q36643929 | ||
| Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities | Q36656593 | ||
| Deubiquitination in virus infection | Q36732782 | ||
| Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases | Q36740202 | ||
| Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes | Q36825432 | ||
| The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation | Q37010771 | ||
| Immune evasion of natural killer cells by viruses | Q37060710 | ||
| Cowpox virus infection: an emerging health threat | Q37100940 | ||
| Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes | Q37110640 | ||
| Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function | Q37157179 | ||
| Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L. | Q37191825 | ||
| Cowpox virus transmission from pet rats to humans, France | Q37203679 | ||
| Cowpox virus transmission from pet rats to humans, Germany | Q37203719 | ||
| The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells. | Q37204575 | ||
| Sensing pathogens and danger signals by the inflammasome | Q37240692 | ||
| Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles | Q37279489 | ||
| A mechanism for the inhibition of fever by a virus | Q37307863 | ||
| Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses | Q37327240 | ||
| Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways | Q37378752 | ||
| A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. | Q37421291 | ||
| Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells | Q37470752 | ||
| Inflammasomes bridge signaling between pathogen identification and the immune response | Q37655058 | ||
| Animal Models ofOrthopoxvirusInfection | Q37777545 | ||
| Interaction of orthopoxviruses with the cellular ubiquitin-ligase system. | Q37779516 | ||
| Vaccinia virus A35R inhibits MHC class II antigen presentation | Q39390434 | ||
| Molecular and cellular biology of intermediate filaments | Q39532153 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virulence | Q1460232 |
| host tropism | Q1536273 | ||
| P304 | page(s) | 524743 | |
| P577 | publication date | 2012-07-30 | |
| P1433 | published in | Advances in virology | Q26842424 |
| P1476 | title | Orthopoxvirus genes that mediate disease virulence and host tropism | |
| P478 | volume | 2012 |
| Q47552709 | 40 Years without Smallpox |
| Q35067198 | An increasing danger of zoonotic orthopoxvirus infections. |
| Q47116100 | Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence? |
| Q36475175 | Attenuation of Vaccinia Virus |
| Q28550799 | Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome |
| Q41142790 | Exploring interaction of TNF and orthopoxviral CrmB protein by surface plasmon resonance and free energy calculation. |
| Q101472204 | Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution |
| Q34070278 | The genome sequence of ectromelia virus Naval and Cornell isolates from outbreaks in North America. |
Search more.